These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Inclusion body myopathy associated with motor neuron syndrome: three case reports. Cafforio G; Pistolesi S; D'Avino C; Galluzzi F; Patricelli A; Solito B; Fontanini G; Siciliano G Clin Neuropathol; 2005; 24(1):36-41. PubMed ID: 15696783 [TBL] [Abstract][Full Text] [Related]
6. Motor neuron syndromes in cancer patients. Forsyth PA; Dalmau J; Graus F; Cwik V; Rosenblum MK; Posner JB Ann Neurol; 1997 Jun; 41(6):722-30. PubMed ID: 9189033 [TBL] [Abstract][Full Text] [Related]
7. Unclassifiable parkinsonism in two European tertiary referral centres for movement disorders. Katzenschlager R; Cardozo A; Avila Cobo MR; Tolosa E; Lees AJ Mov Disord; 2003 Oct; 18(10):1123-31. PubMed ID: 14534915 [TBL] [Abstract][Full Text] [Related]
8. Neurodegenerative overlap syndrome: Parkinsonism and motor neuron disorder. Imamura A; Wszolek Z; Uitti R Mov Disord; 2007 Jan; 22(1):151-2. PubMed ID: 17080444 [No Abstract] [Full Text] [Related]
9. Atypical unclassifiable parkinsonism on Guadeloupe: an environmental toxic hypothesis. Caparros-Lefebvre D; Lees AJ Mov Disord; 2005 Aug; 20 Suppl 12():S114-8. PubMed ID: 16092100 [TBL] [Abstract][Full Text] [Related]
10. A case of presumptive primary lateral sclerosis with upper and lower motor neurone pathology. Short CL; Scott G; Blumbergs PC; Koblar SA J Clin Neurosci; 2005 Aug; 12(6):706-9. PubMed ID: 16098753 [TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study. Shin JY; Park HJ; Ahn YH; Lee PH J Neurochem; 2009 Nov; 111(4):1042-50. PubMed ID: 19765187 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological aspects of motor parkinsonism. Halliday G Parkinsonism Relat Disord; 2007; 13 Suppl 3():S208-10. PubMed ID: 18267237 [TBL] [Abstract][Full Text] [Related]
14. Clinical and neuroimaging characteristics in neurodegenerative overlap syndrome. Lim YM; Park HK; Kim JS; Lee CS; Chung SJ; Kim J; Kim KK Neurol Sci; 2013 Jun; 34(6):875-81. PubMed ID: 22740043 [TBL] [Abstract][Full Text] [Related]
15. New strategies in motor parkinsonism. Antonini A Parkinsonism Relat Disord; 2007; 13 Suppl 3():S446-9. PubMed ID: 18267281 [TBL] [Abstract][Full Text] [Related]
16. [Pronostic factors and survival in motor neuron disease]. Larrode-Pellicer P; Alberti-González O; Iñiguez-Martínez C; Santos Lasaosa S; Pérez-Lázaro C; López del Val LJ Neurologia; 2007; 22(6):362-7. PubMed ID: 17610164 [TBL] [Abstract][Full Text] [Related]
17. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS. Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653 [TBL] [Abstract][Full Text] [Related]
18. Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease. Infante J; Berciano J; Volpini V; Corral J; Polo JM; Pascual J; Combarros O Mov Disord; 2004 Jul; 19(7):848-852. PubMed ID: 15254952 [TBL] [Abstract][Full Text] [Related]
19. [Diagnosis and treatment of patients with parkinsonism in nursing homes: how to improve quality?]. Larsen JP Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1669-71. PubMed ID: 15976838 [TBL] [Abstract][Full Text] [Related]
20. Breast cancer and motor neuron disease: clinical study of seven cases. Sadot E; Carluer L; Corcia P; Delozier Y; Levy C; Viader F Amyotroph Lateral Scler; 2007 Oct; 8(5):288-91. PubMed ID: 17852015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]